Fluorine-18 Market (By Product: FDG, NaF, and Others; By End User: Hospitals, Diagnostic Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Fluorine-18 Market, By Product

7.1.  Fluorine-18 Market, by Product, 2021-2030

7.1.1.     FDG

7.1.1.1.          Market Revenue and Forecast (2016-2030)

7.1.2.     NaF

7.1.2.1.          Market Revenue and Forecast (2016-2030)

7.1.3.     Others

7.1.3.1.          Market Revenue and Forecast (2016-2030)

Chapter 8.    Global Fluorine-18 Market, By End User

8.1.  Fluorine-18 Market, by End User, 2021-2030

8.1.1.     Hospitals

8.1.1.1.          Market Revenue and Forecast (2016-2030)

8.1.2.     Diagnostic Centers

8.1.2.1.          Market Revenue and Forecast (2016-2030)

8.1.3.     Others

8.1.3.1.          Market Revenue and Forecast (2016-2030)

Chapter 9.    Global Fluorine-18 Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.     Market Revenue and Forecast, by Product (2016-2030)

9.1.2.     Market Revenue and Forecast, by End User (2016-2030)

9.1.3.     U.S.

9.1.3.1.          Market Revenue and Forecast, by Product (2016-2030)

9.1.3.2.          Market Revenue and Forecast, by End User (2016-2030)

9.1.4.     Rest of North America

9.1.4.1.          Market Revenue and Forecast, by Product (2016-2030)

9.1.4.2.          Market Revenue and Forecast, by End User (2016-2030)

9.2.  Europe

9.2.1.     Market Revenue and Forecast, by Product (2016-2030)

9.2.2.     Market Revenue and Forecast, by End User (2016-2030)

9.2.3.     UK

9.2.3.1.          Market Revenue and Forecast, by Product (2016-2030)

9.2.3.2.          Market Revenue and Forecast, by End User (2016-2030)

9.2.4.     Germany

9.2.4.1.          Market Revenue and Forecast, by Product (2016-2030)

9.2.4.2.          Market Revenue and Forecast, by End User (2016-2030)

9.2.5.     France

9.2.5.1.          Market Revenue and Forecast, by Product (2016-2030)

9.2.5.2.          Market Revenue and Forecast, by End User (2016-2030)

9.2.6.     Rest of Europe

9.2.6.1.          Market Revenue and Forecast, by Product (2016-2030)

9.2.6.2.          Market Revenue and Forecast, by End User (2016-2030)

9.3.  APAC

9.3.1.     Market Revenue and Forecast, by Product (2016-2030)

9.3.2.     Market Revenue and Forecast, by End User (2016-2030)

9.3.3.     India

9.3.3.1.          Market Revenue and Forecast, by Product (2016-2030)

9.3.3.2.          Market Revenue and Forecast, by End User (2016-2030)

9.3.4.     China

9.3.4.1.          Market Revenue and Forecast, by Product (2016-2030)

9.3.4.2.          Market Revenue and Forecast, by End User (2016-2030)

9.3.5.     Japan

9.3.5.1.          Market Revenue and Forecast, by Product (2016-2030)

9.3.5.2.          Market Revenue and Forecast, by End User (2016-2030)

9.3.6.     Rest of APAC

9.3.6.1.          Market Revenue and Forecast, by Product (2016-2030)

9.3.6.2.          Market Revenue and Forecast, by End User (2016-2030)

9.4.  MEA

9.4.1.     Market Revenue and Forecast, by Product (2016-2030)

9.4.2.     Market Revenue and Forecast, by End User (2016-2030)

9.4.3.     GCC

9.4.3.1.          Market Revenue and Forecast, by Product (2016-2030)

9.4.3.2.          Market Revenue and Forecast, by End User (2016-2030)

9.4.4.     North Africa

9.4.4.1.          Market Revenue and Forecast, by Product (2016-2030)

9.4.4.2.          Market Revenue and Forecast, by End User (2016-2030)

9.4.5.     South Africa

9.4.5.1.          Market Revenue and Forecast, by Product (2016-2030)

9.4.5.2.          Market Revenue and Forecast, by End User (2016-2030)

9.4.6.     Rest of MEA

9.4.6.1.          Market Revenue and Forecast, by Product (2016-2030)

9.4.6.2.          Market Revenue and Forecast, by End User (2016-2030)

9.5.  Latin America

9.5.1.     Market Revenue and Forecast, by Product (2016-2030)

9.5.2.     Market Revenue and Forecast, by End User (2016-2030)

9.5.3.     Brazil

9.5.3.1.          Market Revenue and Forecast, by Product (2016-2030)

9.5.3.2.          Market Revenue and Forecast, by End User (2016-2030)

9.5.4.     Rest of LATAM

9.5.4.1.          Market Revenue and Forecast, by Product (2016-2030)

9.5.4.2.          Market Revenue and Forecast, by End User (2016-2030)

Chapter 10.   Company Profiles

10.1.                 Lantheus Holdings, Inc.

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.                 Siemens Healthineers

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.                 Advanced Accelerator Applications (a Novartis AG Company)

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.                 GE Healthcare (General Electric Company)

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.                 Blue Earth Diagnostics (A Bracco Imaging Company)

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.                 Jubilant Pharma Limited

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.                 China lsotope & Radiation Corporation

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.                 Eli Lilly and Company

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.                 Curium Pharma

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.              Yantai Dongcheng Pharmaceutical Group Co., Ltd.

10.10.1.                   Company Overview

10.10.2.                   Product Offerings

10.10.3.                   Financial Performance

10.10.4.                   Recent Initiatives

Chapter 11.   Research Methodology

11.1.                 Primary Research

11.2.                 Secondary Research

11.3.                 Assumptions

Chapter 12.   Appendix

12.1.                 About Us

12.2.                 Glossary of Terms